PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.75%
Both yoy net incomes decline, with MRVL at -22.76%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.39%
Some D&A expansion while MRVL is negative at -30.89%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
96.10%
Deferred tax of 96.10% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-318.88%
Both reduce yoy usage, with MRVL at -911.21%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-48.15%
Negative yoy inventory while MRVL is 122.16%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-314.61%
Both reduce yoy usage, with MRVL at -493.97%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
91.48%
Lower 'other non-cash' growth vs. MRVL's 1119.78%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-34.44%
Both yoy CFO lines are negative, with MRVL at -66.26%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
16.36%
CapEx growth well above MRVL's 22.16%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
33.62%
Less growth in investment purchases vs. MRVL's 74.15%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-33.09%
We reduce yoy sales while MRVL is 144.51%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-85.71%
We reduce yoy other investing while MRVL is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-251.72%
We reduce yoy invests while MRVL stands at 136.55%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
201.96%
We slightly raise equity while MRVL is negative at -88.80%. John Neff sees competitor possibly preserving share count or buying back shares.
24.16%
Buyback growth of 24.16% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.